bpi 002
Corona Treatment: Vaccines/drugs in the pipeline for COVID-19-updated
Coronavirus vaccine by Medicago Medicago is developing drug candidates against COVID-19 after having produced Virus-Like Particles (VLP) of the coronavirus. The company has formed a collaboration with Laval University’s Infectious Disease Research Centre to develop antibodies against SARS-CoV-2. The company’s research activities are being partly funded by the Canadian Institutes for Health Research (CIHR). AT-100…